Medified blalock-taussing shnt: a palliative procedure for congenital cyanotic heart disease

ABSTRACT

Systemic pulmonary arterial shunt procedure is used in the management of cyanotic congenital heart diseases. We are reporting our experience of 80 procedures with modified Blalock-Taussing shunt procedure in the management of cyanotic heart defects, from January 1994 to December 1994. The age of these patients was 3 months to 15 years. Forty-five [56.2 percent] presented with cyanotic spells and 35 [43.5 percent] were electively selected for surgery. The packed cell volume in majority of the patients ranged between 45 to 70 percent. Seventy-two [90.5 percent] cases received right-sided shunt. The hospital mortality was 5 percent. We conclude modified Blalock Taussing shunt is a useful palliative procedure in the management of cyanotic congenital cardiac defects